Anti-inflammatory Activity and Mechanism of Surfactin in Lipopolysaccharide-Activated Macrophages

Inflammation

Volumn 38, Issue 2, 2015, Pages 756-764

  Zhang, Yuanyuan ^a   Liu, Chuan ^a   Dong, Bin ^a   Ma, Xiaolei ^a   Hou, Lihua ^a   Cao, Xiaohong ^a   Wang, Chunling ^a  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

lipopolysaccharide; macrophages; NF B; pro inflammatory cytokines; Surfactin

Indexed keywords

GAMMA INTERFERON; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SURFACTIN; TOLL LIKE RECEPTOR 4; ANTIINFLAMMATORY AGENT; AUTACOID; CYCLOPEPTIDE; LIPOPEPTIDE; SURFACTIN PEPTIDE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CELL SIGNALING ASSAY; CELL STIMULATION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY ASSAY; DOWN REGULATION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION MEDIATORS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PEPTIDES, CYCLIC;

EID: 84925539933     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9986-y     Document Type: Article

References (19)

1. Lynnette R. Ferguson, William A. Laing 2010. Chronic inflammation, mutation and human disease. Mutation Research 690: 3–11.
2. Weon-Jong Yoon, Young Min Ham, Sang-Suk Kim, et al. 2009. Suppression of pro-inflammatory cytokines, iNOS, and COX-2 expression by brown algae Sargassum micracanthum in RAW 264.7 macrophages. EurAsian Journal of BioSciences EurAsia J BioSci. 3: 130–143.
3. Andreasen, A.S., K.S. Krabbe, R. Krogh-madsen, et al. 2008. Human endotoxemia as a model of systemic inflammation. Current Medicinal Chemistry 15: 1697–1705.
4. Zhu, X., Y. Liu, S. Liu, et al. 2007. Lipopolysaccharide primes macrophages to increase nitric oxide production in response to Staphylococcus aureus. Immunology Letters 112: 75–81.
5. Pastor, C.M., J. Pugin, B. Kwak, et al. 2004. Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia. Critical Care Medicine 32: 1759–1763.
6. Cao, X., A.H. Wang, R.Z. Jiao, C.L. Wang, D.Z. Mao, L. Yan, et al. 2009. Surfactin induces apoptosis and G2/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation. Cell Biochemistry and Biophysics 55: 163–171.
7. Kim, S.Y., J.Y. Kim, S.H. Kim, H.J. Bae, H.S. Yi, S.H. Yoon, et al. 2007. Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Letters 581: 865–871.
8. Qi, G., F. Zhu, P. Du, X. Yang, D. Qiu, Z. Yu, et al. 2010. Lipopeptide induces apoptosis in fungal cells by a mitochondria-dependent pathway. Peptides 31: 1978–1986.
9. Son, G.H., J. Kim, M.J. Muthaiya, S. Lee, H.Y. Kim, and C.H. Lee. 2011. Antimicrobial compounds profile during Cheonggukjang fermentation against Xanthomonas oryzae pv. oryzae (Xoo). Journal of Microbiology and Biotechnology 21: 1147–1150.
10. Sun Young Park, Ji-Hee Kim, Sang Joon Lee, et al. 2013. Involvement of PKA and HO-1 signaling in anti-inflammatory effects of surfactin in BV-2 microglial cells. Toxicology and Applied Pharmacology 1: 68–78.
11. 2+ is associated with mitochondria permeability transition pore involved in surfactin-induced MCF-7 cells apoptosis. Chemico-Biological Interactions 190: 16–27.
12. Moretão, M.P., D.F. Buchi, P.A. Gorin, M. Iacomini, and M.B. Oliveira. 2003. Effect of an acidic heteropolysaccharide (ARAGAL) from the gum of Anadenanthera colubrine (Angico branco) on peritoneal macrophage functions. Immunology Letters 89: 175–185.
13. 2, and proinflammatory cytokines in RAW264.7 macrophages. Journal of Bioscience and Bioengineering 107: 429–438.
14. Bian, K., and F. Murad. 2003. Nitric oxide (NO) biogeneration, regulation, and relevance to human diseases. Frontiers in Bioscience 8: 264–278.
15. West, N.E.J., H.S. Qian, T.J. Guzik, et al. 2001. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation 104: 1526–1532.
16. Brynskov, J., P. Foegh, G. Pedersen, et al. 2002. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 51: 37–43.
17. Locksley, R.M., N. Killeen, and M.J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487–501.
18. Swardfager, W., K. Lanctôt, L. Rothenburg, et al. 2010. A meta-analysis of cytokines in Alzheimer's disease. Biological Psychiatry 68: 930–941.
19. Poltorak, A., X. He, I. Smirnova, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in Tlr4 gene. Science 282: 2085–2088.